Bob's Discount Furniture, a budget retailer of furniture and bedding, raised $331 million by offering 19.5 million shares at $17, the low end of the range of $17 to $19. At the pricing, the company has a market value of $1.3 billion. Bob's Discount Furniture...read more
Updated Monday, 2/2. Eight IPOs raising at least $100 million are currently scheduled for the week ahead. If all eight deals price, it would be the busiest week for sizable offerings since 2021. Only one other week over the past four years has produced seven...read more
Bob's Discount Furniture, a budget retailer of furniture and bedding, announced terms for its IPO on Monday. The Manchester, CT-based company plans to raise $350 million by offering 19.5 million shares at a price range of $17 to $19. At the midpoint of the...read more
Three IPOs and five SPACs priced this week. Six IPOs and two SPACs submitted initial filings. In the first sizable deal of 2026, solid tumor biotech Aktis Oncology (AKTS) priced its upsized IPO at the high end of the range to raise $318 million at a $1.0...read more
Budget furniture retailer Bob's Discount Furniture prices IPO at $17, the low end of the range
Bob's Discount Furniture, a budget retailer of furniture and bedding, raised $331 million by offering 19.5 million shares at $17, the low end of the range of $17 to $19. At the pricing, the company has a market value of $1.3 billion. Bob's Discount Furniture...read more
US IPO Week Ahead: At least 8 sizable IPOs teed up in one of the busiest weeks in four years
Updated Monday, 2/2. Eight IPOs raising at least $100 million are currently scheduled for the week ahead. If all eight deals price, it would be the busiest week for sizable offerings since 2021. Only one other week over the past four years has produced seven...read more
Budget furniture retailer Bob's Discount Furniture sets terms for $350 million IPO
Bob's Discount Furniture, a budget retailer of furniture and bedding, announced terms for its IPO on Monday. The Manchester, CT-based company plans to raise $350 million by offering 19.5 million shares at a price range of $17 to $19. At the midpoint of the...read more
US IPO Weekly Recap: Aktis Oncology leads as first sizable 2026 IPO
Three IPOs and five SPACs priced this week. Six IPOs and two SPACs submitted initial filings. In the first sizable deal of 2026, solid tumor biotech Aktis Oncology (AKTS) priced its upsized IPO at the high end of the range to raise $318 million at a $1.0...read more